WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2024 Issue has been successfully launched on NOVEMBER 2024.

Abstract

VISCUM ALBUM ENHANCES BLOOD SERUM BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) LEVEL IN EXPERIMENTAL MODEL OF ALZHEIMER’S DISEASE

*Edem Edem Ekpenyong, Oremosu Ademola Ayodele, Enye Linus

ABSTRACT

Background: Viscum album (Mistletoe) is a semi-parasitic plant with a documented broad spectrum of therapeutic actions, which include anticancer, immunomodulatory, antidiabetic, antiepileptic and anticonvulsant propensities. The Brain-derived Neurotrophic Factor (BDNF), a protein encoded by the BDNF gene belongs to the neurotrophin family of growth factors; and happens to be the most extensively distributed neurotrophin in the brain where its activation is critical for neuronal survival and neurogenesis. Disturbed BDNF levels have been implicated in the pathogenesis of Alzheimer‟s disease, a neurodegenerative disorder with progressive cognitive deficits and neuronal loss as major hallmarks. The present study was thus designed to investigate the ability of Viscum album to stimulate, as it were, the production of BDNF in the Alzheimer‟s disease Model. Results: Aluminium chloride (150mg/kg body weight) administered daily for twenty one days significantly decreased BDNF levels compared to the Control. Chronic treatment with Viscum album extract (100mg/kg, orally) for a period of 21days, simultaneously with AlCl3 administration; and also beginning 10days after AlCl3 administration, significantly triggered an increase in BDNF serum levels, and attenuated aluminium chloride-induced neurotoxicity. Conclusion: The present study indicates BDNFstimulating and neuroprotective activities of Viscum album against aluminium chlorideinduced neurodegeneration compared to the control mice (p < 0.05). Results of this novel study demonstrate that Viscum album has neuroprotective, therapeutic, as well as BDNFstimulating capacity against aluminium chloride-induced Alzheimer‟s disease Model.

Keywords: Aluminium Chloride, Alzheimer?s disease, BDNF, Neurodegeneration, Viscum album.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More